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Abstract
Background: The possible advantages of laparoscopic radical hysterectomy (LRH) versus open radical hysterectomy
(RH) have not been well reviewed systematically. The aim of this study was to systematically review the
comparative effectiveness between LRH and RH in the treatment of cervical cancer based on the evaluation of the
Perioperative outcomes, oncological clearance, complications and long-term outcomes.
Methods: The systematic review was conducted by searching PubMed, MEDLINE, EMBASE, the Cochrane Library
and BIOSIS databases. All original studies that compared LRH with RH were included for critical appraisal. Data were
pooled and analyzed.
Results: A total of twelve original studies that compared LRH (n = 754) with RH (n = 785) in patients with cervical
cancer fulfilled quality criteria were selected for review and meta-analysis. LRH compared with RH was associated
with a significant reduction of intraoperative blood loss (weighted mean difference = −268.4 mL (95 % CI
−361.6, −175.1; p < 0.01), a reduced risk of postoperative complications (OR = 0.46; 95 % CI 0.34–0.63) and
shorter hospital stay (weighted mean difference = −3.22 days; 95 % CI–4.21, −2.23 days; p < 0.01). These
benefits were at the cost of longer operative time (weighted mean difference = 26.9 min (95 % CI 8.08–45.82).
The rate of intraoperative complications was similar in the two groups. Lymph nodes yield and positive
resection margins were similar between the two groups. There were no significant differences in 5-year
overall survival (HR 0.91, 95 % CI 0.48–1.71; p = 0.76) and 5-year disease-free survival (hazard ratio [HR] 0.97,
95 % CI 0.56–1.68; p = 0.91).
Conclusions: LRH shows better short term outcomes compared with RH in patients with cervical cancer. The
oncologic outcome and 5-year survival were similar between the two groups.
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Background
Cervical cancer is the fourth most common cancer in
women, and the seventh overall. It accounts for 7.5 % of
all female cancer deaths with approximately 266,000
deaths worldwide in 2012. Almost nine out of ten cer-
vical cancer deaths occur in the less developed regions.
In countries that do not have access to cervical cancer
screening and prevention programs, cervical cancer re-
mains the second most common type of cancer (17.8
per 100,000 women) and cause of cancer deaths (9.8 per
100,000) among all types of cancer in women [1, 2].
Radical hysterectomy with pelvic lymphadenectomy is
the standard surgical treatment for patients with early
stage cervical cancer [3]. Although the majority of rad-
ical hysterectomies are performed with the open tech-
nique, laparoscopic, combined laparoscopic and vaginal
and robotic-assisted approaches have been used at sev-
eral centers [4–7]. Compared with the abdominal radical
hysterectomy, laparoscopic techniques are associated
with less blood loss, shorter hospital stay, better cosm-
esis and faster recovery, but questions still remain about
comparative effectiveness with respect to oncological
clearance, complications, recurrence rates and long-term
outcomes [8]. Studies comparing laparoscopy with
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conventional open surgery are limited by their sample
sizes and are not individually powered to detect small
differences in outcomes. A pooled synthesis of these
studies using meta-analysis may provide further insights
into the safety and comparative effectiveness of laparos-
copy and conventional open surgery.
Systematic reviews and meta-analyses have shown
an advantage in short-term outcomes of laparoscopic
(assisted vaginal) and robotic radical hysterectomy
compared with open distal radical hysterectomy [9].
Kucukmetin carried out a systematic review of ran-
domized controlled trials (RCTs) studies that com-
pared open and laparoscopic assisted vaginal radical
hysterectomy (LAVH) in women with early cervical
cancer, but found only one relevant trial which in-
cluded an exceptionally small number of 13 cases.
Due to the small number of cases and the short term
scope of the trial, this article was unable to reach any
definite conclusions regarding the relative benefits
and harms of the two forms of treatment [10]. Thus
far, the potential benefits and disadvantages of LRH
have not been subjected to a scrupulous systematic
review.
The aim of this study was to compare minimally inva-
sive surgery, in particular, total laparoscopic radical hys-
terectomy (LRH) with open radical hysterectomy (RH)
with respect to perioperative outcomes, oncological
clearance, complications and long-term outcomes.
Fig. 1 Flowchart of article screening and selection process
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Methods
Database searching strategy
This review was conducted according to the MOOSE
guidelines for systematic reviews [11]. PubMed, MED-
LINE, EMBASE, the Cochrane Library and BIOSIS data-
bases were searched for: "cervical cancer" AND
"laparoscopic" AND "radical hysterectomy" along with
their synonyms or abbreviations. No additional search
software or special features were used. The last search
update was in December, 2014. The investigators
(Yanzhou Wang and Yao Zhang) independently per-
formed the screening and article selection procedures.
All articles that fulfilled the eligibility criteria were in-
cluded in the systematic review. Authors were contacted
by email in cases where full-text articles were not
available.
Inclusion and exclusion criteria
Studies included in this analysis must have met the fol-
lowing criteria: (1) adult women diagnosed with cervical
cancer; (2) women who had undergone LRH versus RH
as primary treatment; (3) patients who were classified as
International Federation of Gynecology and Obstetrics
(FIGO) stage IA1 with lymphovascular invasion to IIA.
Studies were excluded from the meta-analysis if (1) radi-
ation or concurrent chemoradiation therapy were used
as primary treatment, (2) the surgical approach used was
laparoscopic assisted radical vaginal hysterectomy. In the
case of multiple studies with the same or overlapping
data published by the same researchers, we selected the
most recent study with the largest number of partici-
pants. Using these criteria, duplicate publications with
derivative patients were excluded from our meta-analysis
[12, 13]. One article was excluded for only including pa-
tients with stages IB2 and IIA2 and, therefore, is not
comparable to this current study because this patient
population includes stages IA1 through IIA2 [14].
Data extraction
The following data were collected from each study: first
author’s surname, year of publication, country, partici-
pant characteristics, study design, sample size, blood
Table 1 Main characteristics of 11 studies of LRH and RH
References Design Approach Number Age (years) BMI
(Kg/m2)
Tumor
diameter (cm)
Stage
Ia1 (LVSI) Ia2 Ib1 Ib2 IIa
Bogani et al. [31] Propensity-matched cohort Laparoscopic 65 48.9 ± 13.5 25.1 ± 5.2 - - - - - -
Open 65 50.9 ± 14 25.9 ± 6.1 - - - - - -
Chen et al. [20] Retrospective cohort Laparoscopic 32 51.2 ± 11.9 23.2 ± 3.4 - - - - - -
Open 44 51.9 ± 11.3 24.9 ± 4.6 - - - - - -
Ditto et al. [25] Propensity-matched cohort Laparoscopic 60 46 ± 12.5 24.3 ± 2.9 - - 13 47 - -
Open 60 45.5 ± 15.75 24.0 ± 4.3 - - 10 50 - -
Frumovitz et al. [26] Retrospective cohort Laparoscopic 35 40.8 ± 8.75 28.1 ± 5.6 - 2 5 28 0 -
Open 54 42.5 ± 10.25 28.2 ± 7.25 - 3 8 42 1 -
Ghezzi et al. [27] cohort Laparoscopic 50 47 ± 13.5 23 ± 4.4 2.6 ± 0.9 - 7 30 6 7
Open 48 53 ± 11.8 25 ± 6.0 3.0 ± 1.0 - 2 26 13 7
Lee et al. [21] Retrospectivecohort Laparoscopic 24 48.4 ± 7.25 23.4 ± 3.55 - - 5 13 2 4
Open 48 50.2 ± 8.25 23.9 ± 4.7 - - 10 26 4 8
Li et al. [22] Retrospectivecohort Laparoscopic 90 42 ± 9 - 2.8 ± 1.4 - 60 12 18
Open 35 44 ± 11 - 2.6 ± 1.5 - 14 8 13
Lim et al. [23] Prospectivecohort Laparoscopic 18 47.8 ± 8.8 23.9 ± 4.4 2.9 ± 1.5 - 2 13 3 0
Open 30 47.0 ± 8.5 22.4 ± 4 3 ± 1.2 - 1 23 4 2
Malzoni et al. [28] Retrospectivecohort Laparoscopic 65 40.5 ± 7.7 26.0 ± 4 5 21 39 - -
Open 62 42.7 ± 8.6 29.0 ± 4 3 11 48 - -
Nam et al. [24] Retrospectivematched cohort Laparoscopic 263 46.4 23.2 1.8 ± 0.55 - 36 197 25 5
Open 263 46.5 23.9 1.8 ± 0.75 - 40 194 21 8
Toptas et al. [29] Retrospectivecohort Laparoscopic 22 - - 2.1 ± 1.5 - 9 13 - -
Open 46 - - 2.6 ± 1.07 - 7 39 -
Zakashansky et al. [30] Retrospectivematched cohort Laparoscopic 30 48.3 ± 12.25 - - 1 8 17 2 2
Open 30 46.6 ± 11.75 - - 1 6 19 2 2
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loss, transfusion rate, operative time, duration of hospital
stay, intraoperative complications, postoperative compli-
cations, oncologic outcome (resection margins and mean
nodal counts), recurrence rate, 5-year disease free sur-
vival (DFS) and 5-year overall survival (OS). If data
could be acquired from the tabulated literature search
results, they would be extracted carefully into 2 × 2 ta-
bles from all eligible publications by two independent re-
viewers, based on the inclusion criteria above. In the
study, medians were presented instead of means. Based
on these medians, the means were estimated as (low end
of range +median*2 + high end of range)/4 for a sample
size smaller than 25. For a sample size larger than 25,
the median was used as an estimation for the mean.
When only a range was provided, the standard devia-
tions were estimated as range/4 [15]. With data regard-
ing OS and DFS, HRs with 95 % confidence interval
were not reported, data were extracted from the survival
curves and mathematical HR approximations were per-
formed using established methods [16, 17]. If data were
not directly available, they would be calculated from
published positive predictive values and/or negative pre-
dictive values. If there was unclear or incomplete infor-
mation in the studies, the reviewers would contact the
original authors for verification. Disagreements were re-
solved through discussion between the two reviewers.
Quality evaluation
The NOS (Newcastle-Ottawa scale) is a tool that judges
and evaluates non-randomized studies in meta-analyses
[18]. The scores ranged from 0 to 9 stars. Studies with
scores of 7 stars or greater were considered to be of high
quality. The stars were added up to compare the quality
of the study in a quantitative fashion. Two reviewers in-
dependently evaluated and cross-checked the qualities of
the included studies, as well as assessed the bias of the
studies. An open discussion was held to confirm the
scores of those studies that caused disagreements be-
tween the reviewers.
Statistical methods
All statistical tests were performed using the Cochrane
Collaboration’s Revman5.1. Continuous data are
expressed as mean differences with standard deviations
(SD). Results for comparisons of dichotomous outcomes
(e.g., major postoperative complications) are expressed
as risk differences [or absolute risk reduction, ARR) with
95 % confidence intervals (CI)]. A meta-analysis was
planned if the included studies were clinically homoge-
neous. Heterogeneity among studies was determined by
the Chi-square-based Q test and the I2 statistics. A p
value less than 0.05 for the Q test together with an I2
value greater than 50 % was considered a measure of se-
vere heterogeneity. Therefore, the study was calculated
using the fixed-effect model (the Mantel–Haenszel
method), otherwise, the random-effects model (the Der-
Simonian and Laird method) was used [19]. The publi-
cation bias for each of the pooled study groups was
assessed with a funnel plot. A two-tailed test was used
Table 2 Assessment of study quality
Study Quality indicators from Newcastle-Ottawa scale Score
Selection Comparability Exposure/outcome
1 2 3 4 5a 5b 6 7 8
Bogani et al. [31] Yes NO Yes Yes Yes Yes Yes Yes Yes 9
Chen et al. [20] Yes Yes Yes Yes Yes Yes Yes No Yes 8
Ditto et al. [25] Yes Yes Yes Yes Yes Yes Yes Yes Yes 9
Frumovitz et al. [26] Yes Yes No Yes Yes Yes Yes No Yes 7
Ghezzi et al. [27] Yes Yes No Yes Yes Yes Yes No Yes 7
Lee et al. [21] Yes Yes Yes Yes Yes Yes Yes Yes Yes 9
Li et al. [22] Yes Yes Yes Yes Yes No Yes No No 6
Lim et al. [23] Yes Yes Yes Yes Yes No Yes No Yes 7
Malzoni et al. [28] Yes Yes No Yes Yes Yes Yes Yes Yes 8
Nam et al. [24] Yes Yes Yes Yes Yes No Yes Yes Yes 8
Toptas et al. Yes Yes Yes Yes Yes Yes Yes No Yes 8
Zakashansky et al. [30] Yes Yes Yes Yes Yes Yes Yes No No 7
For case–control studies, 1 indicates cases independently validated; 2 cases are consecutive or representative of population; 3 communitycontrols; 4 controls have
no history of cervical cancer ;5A study controls for sex and age; 5B study controls for any additional factor(s); 6 ascertainment ofexposure by secure record or
blinded interview; 7 same method of ascertainment for cases and controls; and 8 same non-response rate for casesand controls. For cohort studies, 1 indicates
exposed cohort truly representative, 2 the non-exposed cohort drawn from the same community, 3ascertainment of exposure by secure record or structured
interview, 4 outcome of interest was not present at start of study, 5A cohorts comparableon basis of sex and age, 5B cohorts comparable on other factor(s), 6
quality of outcome assessment, 7 follow-up long enough for outcomes tooccur; and 8 complete follow-up
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Table 3 Study outcomes
References Approach Number Operative
time (min)
Blood loss (ml) Transfusion
rate (%)
Nodal counts Duration of
hospital stay
Removal of
foley catheter
Surgical margins
positive
5-years disease
free survival, (%)
5-years overall
survival, (%)
Bogani et al. [31] Laparoscopic 65 245 ± 72.2 200 ± 297.5 4 (6) 23.2 ± 8.2 4 ± 3.3 – – 83 % 89 %
Open 65 259.5 ± 69.6 500 ± 475 14 (22) 27.4 ± 17.2 8 ± 1.8 – – 80 % 83 %
Chen et al. [20] Laparoscopic 32 292.8 ± 65.2 225.0 ± 164.1 8 (25.0) 29.7 ± 15.4 9.0 ± 2.7 – – – –
Open 44 302.9 ± 76.4 1139.0 ± 656.8 33 (75.0) 27.8 ± 11.0 11.2 ± 3.3 – – – –
Ditto et al. [25] Laparoscopic 60 215.9 ± 61.6 50 ± 112.5 1 (2) 25.4 ± 10.0 4 ± 2 – – – –
Open 60 175.2 ± 32.1 200 ± 112.5 3 (5) 34.6 ± 13.5 6 ± 2.8 – – – –
Frumovitz et al. [26] Laparoscopic 35 – 319.0 ± 492.0 11 (31.4) – – 13.5 ± 4.5 3 (8.6) – –
Open 54 – 548.0 ± 387.5 15 (27.8) – – 13 ± 9.3 2 (3.7) – –
Ghezzi et al. [27] Laparoscopic 50 – – 0 21 ± 10.3 6 ± 2.8 – 3 (6.0) – –
Open 48 – – 4 (8) 23 ± 10.8 10 ± 7.0 – 3 (6.2) – –
Lee et al. [21] Laparoscopic 24 334.8 ± 52.4 414.3 ± 69.2 5 (20.8) 26.3 ± 11.8 – – 0 90.5 –
Open 48 326.8 ± 53.8 836.0 ± 315.8 23 (47.9) 26.8 ± 13.6 – – 0 93.3 –
Li et al. [22] Laparoscopic 90 263.0 ± 67.6 369.8 ± 249.9 – 21.3 ± 8.4 – 10.7 ± 7.2 – – –
Open 35 217.2 ± 71.6 455.1 ± 338.1 – 18.8 ± 9.5 – 8.6 ± 6.8 – –
Lim et al. [23] Laparoscopic 18 308.0 ± 66.0 425 ± 225 – 17 ± 7.5 5.5 ± 1.5 19.5 ± 10.3 – –
Open 30 240.0 ± 90.0 500 ± 1455 – 21.0 ± 11.8 6 ± 6.5 21.0 ± 11.8 – –
Malzoni et al. [28] Laparoscopic 65 196.0 ± 14.5 55.0 ± 12.5 – 23.5 ± 5.1 – 10 ± 2 – 92.4 –
Open 62 152.0 ± 19.8 145.0 ± 41.3 – 25.2 ± 6.2 – 13 ± 2.5 – 93.6 –
Nam et al. [24] Laparoscopic 263 246.8 ± 84.8 379.6 ± 350.0 76 (28.9) – – 7.2 ± 1.5 1 (0.4) 92.8 95.2
Open 263 247.2 ± 86.3 541.1 ± 730.0 106 (40.3) – – 7.5 ± 4.3 2 (0.8) 94.4 96.4
Toptas et al. 2014 Laparoscopic 22 – – – – – – 1 (4.5) – –
Open 46 – – – – – – 1 (2.2) – –
Zakashansky et al. [30] Laparoscopic 30 318.5 ± 66.0 200.0 ± 125.0 0 31.0 ± 12.8 – – – – –
Open 30 242.5 ± 69.5 520.0 ± 375.0 5 (16.7) 21.8 ± 8.5 – – – – –
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to assess the funnel plot asymmetry; the significance was
set at p < 0.05 level.
Results
Description of the studies
The selection process and result are schematically illus-
trated in Fig. 1. A total of 12 cohort studies were identi-
fied, all of which were accessible in full-text format. We
established a database according to the information ex-
tracted from each article. Detailed characteristics of the
11 studies are listed in Table 1. A total of 754 LRH and
785 RH cases were included into our meta-analysis.
Quality assessment of the studies was performed using
the NOS method. The results ranged from a star rating
of 6–9 (with a mean star rating of 7.75), with a higher
value indicating the better methodology (Table 2).
The majority of the patients in 5 studies were of Asian
origin and consisted of a total of 847 patients (55.0 %)
[20–24]. The remaining 7 studies were European and
American, comprising692 patients (39.9 %) [25–31]. In-
clusion of patients was limited to those defined with
FIGO stage IA1 [with lymph vascular space invasion
(LVSI)] to IIA cervical cancer. The mean age ranged
between 40.5 and 53.0 years. The reported BMI of Asian
(means ranging between 22.4 and 24.9 kg/m2) was differ-
ent from that of European (with means ranging between
23.0 and 29.0 kg/m2). The tumor diameter was similar
between the two groups.
The mean duration of the surgical procedure was de-
scribed in the nine studies (Table 3) [20–25, 28, 30, 31].
The procedure was found to be longer for LRH in most of
studies [weighted mean difference = 26.9 min (95 % CI
8.08–45.82; p < 0.05] (Fig. 2). The mean operative time for
the laparoscopic technique was (251.5 ± 78.3) min,
whereas it shortened to (240.0 ± 85.1) min for the open
technique. In nine studies [20–26, 28, 30, 31], a reduction
of blood loss was seen in the LRH vs. RH group [weighted
mean difference = −268.4 mL (95 % CI −361.6,-175.1; p <
0.01] (Table 3; Fig. 2). The mean blood loss was (285.4 ±
311.1) mL in LRH compared with (524.1 ± 650.8) mL in
RH, but the risk of requiring a blood transfusion was not
significantly different in the laparoscopy and laparotomy
groups (OR =0.11, 95 % CI: 0.01 to1.01; p = 0.05; Fig. 2).
The mean hospital stay was shorter for LRH pa-
tients (weighted mean difference = −3.22 days; 95 %
CI-4.21 to −2.23 days; p < 0.01; Fig. 2). There was no
Fig. 2 Forest plots: perioperative outcomes between LRH and RH in the treatment of cervical cancer. a Operative time. b Blood loss. c Blood
transfusion rate. d Duration of hospital stay. e Time for Foley catheterization
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difference between the two groups in the time for
Foley catheterization (weighted mean difference =
−0.55 days; 95 % CI −2.48 to 1.38 days; p =0.58;
Fig. 2).
The number of dissected lymph nodes reported in
eight studies (Table 3) [20–23, 25, 27, 28, 30, 31] showed
comparable difference in both techniques (weighted
mean difference = −1.06; 95 % CI −4.03 to 1.91; p = 0.48;
Fig. 3). None of the studies reported a significant differ-
ence in positive resection margins using LRH and RH
(OR = 1.24; 95 % CI 0.46–3.35; p = 0.67; Fig. 3).
The rate of intraoperative complications was similar in
the two groups (6.4 % LRH vs. 4.9 % RH; OR = 1.36; 95 %
CI 0.86–2.15; p = 0.19 Fig. 3; Table 4). Bladder injury oc-
curred in 3.0 % of the LRH patients compared with 2.2 %
of the RH patients (p = 0.309). Urethral injury was found in
1.2 % in LRH group compared with of 0.8 % in RH group
(p = 0.425). Bowel injury was found in 0.3 % of patients in
both groups (p = 0.992). Vascular injury occurred in 1.5 %
of the LRH patients and in 1.4 % of the RH patients (p =
0.809) [20–22, 24, 26–28, 30, 31].
Postoperative complications were addressed in 11 studies
(Additional file 1) [20–28, 30, 31]. The rate of postoperative
surgical complications was lower for LRH versus RH
groups (10.1 vs. 20.1 %; OR = 0.46; 95 % CI 0.34–0.63;
p < 0.001; Fig. 3). The rates of wound infection (0.14 % vs.
0.94 %, p = 0.034), febrile morbidity (1.91 % vs. 4.74 %, p =
0.004), wound dehiscence (0.41 % vs. 2.30 %, p = 0.002) and
ileus (0.82 % vs. 2.30 %, p = 0.022) were higher in the RH
group compared to the LRH groups, where the difference
was statistically significant. The rates of urinary tract infec-
tions, pelvic abscess, postoperative bleeding and ureteral
stricture were also higher in the RH group, but these out-
comes did not reached statistical significance. In contrast
the rates of urinary tract fistula formation were higher in
the LRH group without statistical significance.
Fig. 3 oncological clearance, complications and long-term outcomes between LRH and RH in the treatment of cervical cancer. a Number of
dissected lymph nodes. b Positive resection margins. c Intraoperative complications. d Postoperative complications. e Overall survival, f 5-years
disease-free survival
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Among the total 11 studies, only 3 of them reported
5-year overall survival [24, 25] and in 5 studies, 5-year
disease-free survival [21, 24, 25, 28, 31]. The differences
in 5-year OS (HR 0.91, 95 % CI 0.48–1.71; p = 0.76) and
DSF (hazard ratio [HR] 0.97, 95 % CI 0.56–1.68; p =
0.91) were not significant (Fig. 3).
We used the funnel plot (Fig. 4) to examine the results
of this meta-analysis. The shape of the funnel plots was
nearly symmetrical on both sides of the perpendicular
line (real value), indicating that the publication bias of
these studies was not obvious. In order to investigate
the reliability of the results, we analyzed their sensitiv-
ity. A fixed-effect and random-effect model was applied.
The differences in the standardized means and the 95 %
CIs between the two methods were small. Therefore,
both the sensitivity and the publication bias analysis
suggested that the meta-analysis results were reliable.
Discussion
This meta-analysis was to compare LRH to RH by
means of a thorough evaluation of the available evi-
dence. All included studies were nonrandomized, non-
blinded, comparative cohort studies. The studies with
a high risk of bias were excluded from this meta-
analysis. NOS method was applied and combined with
a critical appraisal in order to provide a reliable indi-
cation of study quality. Unfortunately, the reporting
of study methods and potential confounders was in-
sufficient in several studies. Moreover, the selected
studies were comparative cohort studies. Thus far, no
prospective randomized controlled studies are avail-
able. Two prospective randomized controlled trials
(RTCs, NCT01258413 and NCT00614211) has been
designed in patients with early cervical cancer treated
with laparoscopic vs. abdominal radical hysterectomy,
Table 4 Perioperative complications
References Approach Number Intra-operative complication
Bladder injury Urethral injury Bowel injury Vascular injury Others
Bogani et al. [31] Laparoscopic 65 1 1 0 0 1
Open 65 0 0 0 2 1
Chen et al. [20] Laparoscopic 32 1 0 0 0 0
Open 44 0 2 0 1 0
Ditto et al. [25] Laparoscopic 60 0 0 0 0 0
Open 60 0 0 0 0 0
Frumovitz et al. [26] Laparoscopic 35 1 0 0 3 0
Open 54 1 0 0 0 0
Ghezzi et al. [27] Laparoscopic 50 3 1 0 0 0
Open 48 2 0 1 2 0
Lee et al. [21] Laparoscopic 24 0 1 0 2 0
Open 48 2 1 0 3 0
Li et al. [22] Laparoscopic 90 4 0 0 4 0
Open 35 0 0 0 1 0
Lim et al. [23] Laparoscopic 18 0 0 0 0 0
Open 30 0 0 0 0 0
Malzoni et al. [28] Laparoscopic 65 1 0 0 0 2
Open 62 0 0 0 0 0
Nam et al. [24] Laparoscopic 263 9 6 2 2 0
Open 263 11 3 0 0 1
Zakashansky et al. [30] Laparoscopic 30 2 0 0 0 0
Open 30 0 0 1 1 0
Total Laparoscopic 732 22 (3.0) 9 (1.2) 2 (0.3) 11 (1.5) 3 (0.4)
Open 739 16 (2.2) 6 (0.8) 2 (0.3) 10 (1.4) 2 (0.3)
P Value - - 0.309 0.425 0.992 0.809 0.6465
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but has not provided results yet [32 ]. We believe
that this present meta-analysis gives an overview of
the best available knowledge in this field.
We found that duration of the surgical procedure was lon-
ger in LRH vs. RH in the majority of the studies. We also
demonstrated that patients treated with LRH recovered fas-
ter than those treated with RH in a functional manner. This
is most likely contributed to by the less surgically induced
trauma encountered during the procedure. The reduction of
blood loss and shorter hospital stay in the LRH group partly
supported this hypothesis. Besides these findings, the rates
of intraoperative complications were similarly low in both
groups. The most frequent intraoperative complications in
the LRH group were injuries to the organs such as bladder,
ureter and rectum and to great vessels. The repair of injured
vessels most frequently required the conversion of laparos-
copy to laparotomy. The rates of postoperative complica-
tions were significantly lower in the LRH than in the RH
group. This was especially true for infectious complications,
febrile morbidity, wound infection and wound dehiscence,
all of which have been attributed to the laparotomy itself.
In addition, parametrial disease is an independent pre-
dictor of recurrence-free survival of cervical cancer pa-
tients. Some researchers believe that LRH is performed
using an uterine manipulator, which makes the estima-
tion of adequate vaginal resection difficult, and can po-
tentially lead to tumor spillage, especially when the
vagina is opened and the tumor surface is exposed to
circulating CO2 [33]. Therefore, objective evidence that
LRH can achieve at least the same extent of resection as
in RH should be provided before using them interchange-
ably. Our meta-analysis did find no differences between
the two types of surgery in terms of positive surgical mar-
gins and lymph nodes yield. This does suggest that laparo-
scopically managed patients with cervical cancer undergo
a similar extent of surgery as those treated with the con-
ventional RH. So far, no meta-analysis has summarized
the long-term survival rate of cervical cancer. Only a few
studies reported the survival outcomes. Our analysis
showed that survival outcomes of the laparoscopic and
classical open modalities were comparable, but statistical
difference was hard to assess due to the insufficient data
of the selected studies which included the unclear use and
duration of adjuvant therapy as well as the limited number
of data describing long-term survival after LRH versus
RH.. It is plausible that these factors may have influenced
the overall and disease-free survival of patients.
This study has some limitations that should be recog-
nized when interpreting the results. Firstly, the cohort
studies might be subjected to selection bias. Secondly,
case selection may have caused the more advanced cer-
vical cancer cases not to be considered for LRH and
thirdly the selected studies in this meta-analysis can be
seen as pioneer studies and therefore there is probably a
learning curve associated with them that may have influ-
enced the results in a negative manner.
Conclusion
Our meta-analysis showed that LRH is a safe and feas-
ible procedure to treat the early stage of cervical cancer.
Fig. 4 Funnel plot of studies evaluating the postoperative complications between LRH and RH groups
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This was evidently supported by reduced blood loss,
lower rates of postoperative complications, and faster
functional recovery, with a cost of longer operative time
found in LRH groups by our meta-analysis. Other out-
comes including lymph nodes yield, positive resection
margins, 5-year overall survival and 5-year disease-free
survival by the two surgical techniques were similar.
Further research in the form of prospective RCTs is war-
ranted to evaluate long-term survival outcomes. In our
opinion, future research should be directed at determin-
ing oncologic outcome, survival and quality of life in
addition to the outcomes reported in this review.
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